| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $281.6M | +34.8% |
| Cost of Revenue | $71.4M | +108.2% |
| R&D Expense | $18.3M | +490.3% |
| SG&A Expense | $91.1M | -6.3% |
| Operating Income | $46.0M | +7766.7% |
| Interest Expense | $25.3M | -42.9% |
| Pre-tax Income | $22.7M | +159.3% |
| Income Tax | $2.1M | +231.3% |
| Net Income | $20.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $40.4M | +27.4% |
| Inventory | $30.3M | +79.3% |
| Current Assets | $126.9M | +0.4% |
| Total Assets | $287.2M | -13.4% |
| Current Liabilities | $74.9M | -8.1% |
| Long-term Debt | $282.9M | -10.7% |
| Total Liabilities | $372.8M | -9.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.7M | +298.4% |
| Capital Expenditures | $22.2M | +91.4% |
| Investing Cash Flow | -$32.6M | +14.0% |
| Financing Cash Flow | -$11.0M | -135.3% |
| Free Cash Flow | $2.5M | +146.3% |
| +156.1% |
| EPS (Basic) | $0.73 | +145.6% |
| EPS (Diluted) | $0.71 | +144.4% |
| Stockholders' Equity |
| -$85.6M |
| -9.7% |